[Congressional Record Volume 156, Number 153 (Monday, November 29, 2010)]
[Senate]
[Page S8209]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
EMBRYONIC STEM CELL RESEARCH
Mr. SPECTER. Mr. President, I had spoken about this when we
reconvened several weeks ago, that it is my hope that Congress, the
Senate specifically, will take up legislation which I have introduced
which would authorize the use of Federal funding for embryonic stem
cell research. Embryonic stem cell research holds enormous potential.
You take the embryos which are the most flexible of all of the stem
cells and they can replace diseased parts of the body and they offer
promise of a veritable fountain of youth.
The U.S. District Court for the District of Columbia said the
Executive order issued by President Obama was invalid. But Congress has
the authority to legislate to cure any defect. The case is on appeal to
the circuit court, and a stay has been issued. But the scientists are
very apprehensive, as they testified before the Labor, Health and Human
Services Subcommittee. There are some 200 projects with some $200
million involved.
It is not a constitutional matter. It is a matter of statutory
interpretation on the existing statute. But to the extent there is any
ambiguity, this is something which we ought to address and we ought to
address promptly because it is a life-and-death matter. As long as the
litigation is pending in the Federal court, the scientists do not know
which way to turn. So they have made their point very clear.
The case could go on for a very protracted period of time when you
have to file briefs, have argument, and a decision in the Court of
Appeals for the District of Columbia. Then a possible petition for
certiorari could take a matter of years. With the ideological issues
involved, who knows what the final outcome would be in the judicial
system. But that can all be put to rest by legislation.
____________________